Viral RNA detection by RIG-I-like receptors

Current Opinion in Immunology

Volumn 32, Issue , 2015, Pages 48-53

  Yoneyama, Mitsutoshi ^a   Onomoto, Koji ^a   Jogi, Michihiko ^a   Akaboshi, Teppei ^a   Fujita, Takashi ^b  

^a CHIBA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; HELICASE; INTERFERON; LABORATORY OF GENETICS AND PHYSIOLOGY 2 PROTEIN; MELANOMA DIFFERENTIAITON ASSOCIATED GENE 5 PROTEIN; PATTERN RECOGNITION RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 1; RETINOIC ACID INDUCIBLE GENE I LIKE RECEPTOR; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS RNA; DEAD BOX PROTEIN; PROTEIN BINDING;

ANTIVIRAL STRESS GRANULE; AUTOIMMUNE DISEASE; CARBOXY TERMINAL SEQUENCE; CASPASE RECRUITMENT DOMAIN; CELL GRANULE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CYTOKINE RELEASE; HUMAN; INTERFERON PRODUCTION; MITOCHONDRIAL ANTIVIRAL SIGNALING; MOLECULAR RECOGNITION; NONHUMAN; OLIGOMERIZATION; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REVIEW; RNA VIRUS INFECTION; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGICAL STRESS;

ANIMALS; DEAD-BOX RNA HELICASES; HUMANS; IMMUNITY, INNATE; PHOSPHORYLATION; PROTEIN BINDING; RNA, VIRAL; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; UBIQUITIN;

EID: 84921047960     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.12.012     Document Type: Review

References (57)

1. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5:730-737.
2. Yoneyama M., Fujita T. Recognition of viral nucleic acids in innate immunity. Rev Med Virol 2010, 20:4-22.
3. Gack M.U., Shin Y.C., Joo C-H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z., Inoue S., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
4. Jiang X., Jiang X., Kinch L.N., Kinch L.N., Brautigam C.A., Brautigam C.A., Chen X., Du F., Grishin N.V., Chen Z.J. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 2012, 36:959-973.
5. Sadler A.J., Williams B.R.G. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008, 8:559-568.
6. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
7. Weber M., Gawanbacht A., Habjan M., Rang A., Borner C., Schmidt A.M., Veitinger S., Jacob R., Devignot S., Kochs G., et al. Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 2013, 13:336-346.
8. Goubau D., Schlee M., Deddouche S., Pruijssers A.J., Zillinger T., Goldeck M., Schuberth C., Van der Veen A.G., Fujimura T., Rehwinkel J., et al. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates. Nature 2014, 514:372-375.
9. Wang Y., Ludwig J., Schuberth C., Goldeck M., Schlee M., Li H., Juranek S., Sheng G., Micura R., Tuschl T., et al. Structural and functional insights into 5'-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat Struc Mol Biol 2010, 17:781-787.
10. Jiang F., Ramanathan A., Miller M.T., Tang G-Q., Gale M., Patel S.S., Marcotrigiano J. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 2011, 479:423-427.
11. Civril F., Bennett M., Moldt M., Deimling T., Witte G., Schiesser S., Carell T., Hopfner K-P. The RIG-I ATPase domain structure reveals insights into ATP-dependent antiviral signalling. EMBO Rep 2011, 12:1127-1134.
12. Kowalinski E., Lunardi T., McCarthy A.A., Louber J., Brunel J., Grigorov B., Gerlier D., Cusack S. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 2011, 147:423-435.
13. Runge S., Sparrer K.M.J., Lässig C., Hembach K., Baum A., García-Sastre A., Söding J., Conzelmann K-K., Hopfner K-P. In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathog 2014, 10:e1004081.
14. Saito T., Hirai R., Loo Y.M., Owen D., Johnson C.L., Sinha S.C., Akira S., Fujita T., Gale M. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci 2007, 104:582-587.
15. Takahasi K., Kumeta H., Tsuduki N., Narita R., Shigemoto T., Hirai R., Yoneyama M., Horiuchi M., Ogura K., Fujita T., et al. Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptors. J Biol Chem 2009, 284:17465-17474.
16. Wu B., Peisley A., Richards C., Yao H., Zeng X., Lin C., Chu F., Walz T., Hur S. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 2013, 152:276-289.
17. Funabiki M., Kato H., Miyachi Y., Toki H., Motegi H., Inoue M., Minowa O., Yoshida A., Deguchi K., Sato H., et al. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity 2014, 40:199-212.
18. Rice G.I., del Toro Duany Y., Jenkinson E.M., Forte G.M.A., Anderson B.H., Ariaudo G., Bader-Meunier B., Baildam E.M., Battini R., Beresford M.W., et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 2014, 46:503-509.
19. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo Y-M., Gale M., Akira S., et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005, 175:2851-2858.
20. Satoh T., Kato H., Kumagai Y., Yoneyama M., Sato S., Matsushita K., Tsujimura T., Fujita T., Akira S., Takeuchi O. From the Cover: LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci 2010, 107:1512-1517.
21. Venkataraman T., Valdes M., Elsby R., Kakuta S., Caceres G., Saijo S., Iwakura Y., Barber G.N. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol 2007, 178:6444-6455.
22. Deddouche S., Goubau D., Rehwinkel J., Chakravarty P., Begum S., Maillard P.V., Borg A., Matthews N., Feng Q., van Kuppeveld F.J.M., et al. Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells. eLife 2014, 3:e01535.
23. Bruns A.M., Bruns A.M., Leser G.P., Leser G.P., Lamb R.A., Lamb R.A., Horvath C.M., Horvath C.M. The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly. Mol Cell 2014, 55:771-781.
24. Narita R., Takahasi K., Murakami E., Hirano E., Yamamoto S.P., Yoneyama M., Kato H., Fujita T. A novel function of human pumilio proteins in cytoplasmic sensing of viral infection. PLoS Pathog 2014, 10:e1004417.
25. Suthar M.S., Ramos H.J., Brassil M.M., Netland J., Chappell C.P., Blahnik G., McMillan A., Diamond M.S., Clark E.A., Bevan M.J., et al. The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness. Immunity 2012, 37:235-248.
26. Takamatsu S., Onoguchi K., Onomoto K., Narita R., Takahasi K., Ishidate F., Fujiwara T.K., Yoneyama M., Kato H., Fujita T. Functional characterization of domains of IPS-1 using an inducible oligomerization system. PLoS ONE 2013, 8:e53578.
27. Dixit E., Boulant S., Zhang Y., Lee A.S.Y., Odendall C., Shum B., Hacohen N., Chen Z.J., Whelan S.P., Fransen M., et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 2010, 141:668-681.
28. Horner S.M., Liu H.M., Park H.S., Briley J., Gale M. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci 2011, 108:14590-14595.
29. Brubaker S.W., Gauthier A.E., Mills E.W., Ingolia N.T., Kagan J.C. A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity. Cell 2014, 156:800-811.
30. Peisley A., Bin Wu Yao H., Walz T., Hur S. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol Cell 2013, 51:573-583.
31. Patel J.R., Jain A., Chou Y.-Y., Baum A., Ha T., García-Sastre A. ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon. EMBO Rep 2013, 14:780-787.
32. Myong S., Cui S., Cornish P.V., Kirchhofer A., Gack M.U., Jung J.U., Hopfner K-P., Ha T. Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent translocase on double-stranded RNA. Science 2009, 323:1070-1074.
33. Hou F., Sun L., Zheng H., Skaug B., Jiang Q-X., Chen Z.J. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146:448-461.
34. Xu H., He X., Zheng H., Huang L.J., Hou F., Yu Z., la Cruz de M.J., Borkowski B., Zhang X., Chen Z.J., et al. Structural basis for the prion-like MAVS filaments in antiviral innate immunity. eLife 2014, 3:e01489.
35. Wu B., Peisley A., Tetrault D., Li Z., Egelman E.H., Magor K.E., Walz T., Penczek P.A., Hur S. Molecular imprinting as a signal-activation mechanism of the viral RNA sensor RIG-I. Mol Cell 2014, 55:511-523.
36. Peisley A., Lin C., Wu B., Orme-Johnson M., Liu M., Walz T., Hur S. Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition. Proc Natl Acad Sci 2011, 108:21010-21015.
37. Peisley A., Jo M.H., Lin C., Wu B., Orme-Johnson M., Walz T., Hohng S., Hur S. Kinetic mechanism for viral dsRNA length discrimination by MDA5 filaments. Proc Natl Acad Sci 2012, 109:E3340-E3349.
38. Berke I.C., Yu X., Modis Y., Egelman E.H. MDA5 assembles into a polar helical filament on dsRNA. Proc Natl Acad Sci 2012, 109:18437-18441.
39. Berke I.C., Modis Y. MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA. EMBO J 2012, 31:1714-1726.
40. Onomoto K., Jogi M., Yoo J-S., Narita R., Morimoto S., Takemura A., Sambhara S., Kawaguchi A., Osari S., Nagata K., et al. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS ONE 2012, 7:e43031.
41. Onomoto K., Yoneyama M., Fung G., Kato H., Fujita T. Antiviral innate immunity and stress granule responses. Trends Immunol 2014, 35:420-428.
42. Langereis M.A., Feng Q., van Kuppeveld F.J. MDA5 localizes to stress granules, but this localization is not required for the induction of type I interferon. J Virol 2013, 87:6314-6325.
43. Shigemoto T., Kageyama M., Hirai R., Zheng J., Yoneyama M., Fujita T. Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J Biol Chem 2009, 284:13348-13354.
44. Zeng W., Sun L., Jiang X., Chen X., Hou F., Adhikari A., Xu M., Chen Z.J. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141:315-330.
45. Peisley A., Wu B., Xu H., Chen Z.J., Hur S. Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 2014, 509:110-114.
46. Oshiumi H., Miyashita M., Matsumoto M., Seya T. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog 2013, 9:e1003533.
47. Kuniyoshi K., Takeuchi O., Pandey S., Satoh T., Iwasaki H., Akira S., Kawai T. Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity. Proc Natl Acad Sci 2014, 111:5646-5651.
48. Versteeg G.A., Rajsbaum R., Sánchez-Aparicio M.T., Maestre A.M., Valdiviezo J., Shi M., Inn K-S., Fernandez-Sesma A., Jung J., García-Sastre A. The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity 2013, 38:384-398.
49. Narayan K., Waggoner L., Pham S.T., Hendricks G.L., Waggoner S.N., Conlon J., Wang J.P., Fitzgerald K.A., Kang J. TRIM13 is a negative regulator of MDA5-mediated type I interferon production. J Virol 2014, 88:10748-10757.
50. Liu S., Chen J., Cai X., Wu J., Chen X., Wu Y-T., Sun L., Chen Z.J. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. eLife 2013, 2:e00785.
51. Cui J., Song Y., Li Y., Zhu Q., Tan P., Qin Y., Wang H.Y., Wang R.F. USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell Res. 2014, 24:400-416.
52. Fan Y., Mao R., Yu Y., Liu S., Shi Z., Cheng J., Zhang H., An L., Zhao Y., Xu X., et al. USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. J Exp Med 2014, 211:313-328.
53. Pauli E-K., Chan Y.K., Davis M.E., Gableske S., Wang M.K., Feister K.F., Gack M.U. The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25. Sci Signal 2014, 7:ra3-ra3.
54. Wang L., Zhao W., Zhang M., Wang P., Zhao K., Zhao X., Yang S., Gao C. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. J Virol 2013, 87:4507-4515.
55. Sun Z., Ren H., Liu Y., Teeling J.L., Gu J. Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J Virol 2011, 85:1036-1047.
56. Wies E., Wang M.K., Maharaj N.P., Chen K., Zhou S., Finberg R.W., Gack M.U. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 2013, 38:437-449.
57. Goubau D., Deddouche S., Reis Sousa C. Cytosolic sensing of viruses. Immunity 2013, 38:855-869.